News Related to Mesenchymal Stem Cells

Related coverage linked through entity extraction aliases.

Growth and Differentiation Factors Market Projected to Grow at 8.2% CAGR Through 2035

Jun 06, 2026

The global growth and differentiation factors market is projected to grow at an 8.2% CAGR through 2035, driven by expanding cell therapy manufacturing. GMP-grade revenue is expected to surpass research-grade by 2030 as the industry transitions to clinical and commercial production.

Brainstorm Cell Therapeutics Secures $1M Financing for ALS Phase IIIb Trial

Mar 12, 2026

Brainstorm Cell Therapeutics announced a $1 million private placement at a premium to market price to support its upcoming Phase IIIb trial of NurOwn stem cell therapy for amyotrophic lateral sclerosis.